drugset / Trial / NCT05588557
A Phase I Study to Evaluate the Safety and PK of ND-340 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
This study focuses on ND-340 extended release injection suspension for healthy volunteers with a one-time nerve blockade to determine the safety, tolerability, and pharmacokinetic profile.
Timeline
- Start
- 2022-07-08
- Primary completion
- 2024-03-19
- Completion
- 2024-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 150 mg | Other |
| Subject | Bupivacaine | Other / unclassified | — | Other |